Eisai shares rise as FDA memo raises hopes for full approval of Alzheimer’s drug
June 07, 2023 at 22:00 PM EDT
Eisai shares rose sharply Thursday morning after the U.S. Food and Drug Administration's review memo on Leqembi raised expectations for full approval of the Alzheimer's drug.
